Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

BACKGROUND: The objective of this study was to compare the efficacy of biomarkers in assessing the risk of breast cancer recurrence in patients with node-negative or micrometastatic grade II breast cancer. Specifically, we compared risk assessments based on the St. Gallen clinicopathological criteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Deluche, Elise, Venat-Bouvet, Laurence, Leobon, Sophie, Fermeaux, Veronique, Mollard, Joelle, Saidi, Nadira, Jammet, Isabelle, Aubard, Yves, Tubiana-Mathieu, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618730/
https://www.ncbi.nlm.nih.gov/pubmed/28954632
http://dx.doi.org/10.1186/s12885-017-3648-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618730/
https://www.ncbi.nlm.nih.gov/pubmed/28954632
http://dx.doi.org/10.1186/s12885-017-3648-z

Ejemplares similares